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INTRODUCTION
The major constraint in the National
Tuberculosis Programme in India is poor treatment
completion with the conventional 12-18 month
regimens1,2. One of the main reasons for this poor
treatment adherence is the prolonged treatment
period. It is, therefore, logical to employ treatment
regimens of shorter duration with an aim to improve
the treatment adherence by patients. The efficacy
of Short Course Chemotherapy (SCC) regimens, of
6-9 months’ duration, containing powerful
bactericidal and sterilising drugs, at least during the
initial 2 months, has been established in the treatment
of newly diagnosed sputum positive pulmonary
tuberculosis and these regimens have been widely
recommended3,4,5. Further, the drug regimens
employed in SCC rendered the vast majority of
patients non-infectious in a short period. Even if a
patient with initially drug-sensitive organisms
defaults after 3 months of chemotherapy with a
regimen containing Streptomycin plus Isoniazid
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plus Rifampicin plus Pyrazinamide daily, he stands
a good chance ofattaining sputum conversion (about
95% by 3 months)6, and remaining negative thereafter
(about 80% up to 5 years of follow-up)7.
Considering these advantages, the
Government of India introduced SCC as a pilot
project under the existing District Tuberculosis
Programme (DTP) in 18 districts spread all over
India. The objective was to find out the feasibility of
introducing SCC regimens under the existing
programme conditions in all districts and to evaluate
their acceptability.
MATERIAL AND METHODS
The project was undertaken between 1983
and 1991. The 18 districts where SCC was
implemented were widely distributed all over India,
involving 9 states and one union territory. There
were 3 districts each in 4 states, 1 each in 5 states and
one in a Union Territory. The population, according
to the 1981 census, was below 1 million in 3
districts, 1-2 million in 5 districts, 2-3 million in 6
districts, 3-4 million in 3 districts and above 4
million in one district; the total population covered
being about 40 million (Annexure).
Eligibility for Treatment with SCC regimens
Chest symptomatics* aged 15 years or more,
belonging to the districts concerned, with at least
one sputum smear found positive for acid-fast bacilli
(APB), who had not had more than 2 months of
previous specific anti-tuberculosis chemotherapy
and were attending the government health facilities
on their own were considered eligible.
SCC regimens
The regimens prescribed were as follows:
Regimen 1: 2RHZ2/4RH2: A fully supervised 6-
month intermittent regimen consisting of Rifampicin
600mg, Isoniazid 600mg and Pyrazinamide 2.0g for
2 months, followed by Rifampicin 600mg and
Isoniazid 600mg for the next 4 months, all the doses
administered twice-weekly in the clinic under
supervision.
Regimen 2: 2RHZ/6TH: A fully unsupervised
daily 8-month regimen consisting of Rifampicin
450mg, Isoniazid 300mg and Pyrazinamide 1.5g for
2 months, followed by Thioacetazone 150mg and
Isoniazid 300mg for the next 6 months, all the doses
being collected by the patients twice-a-month for
self administration
Regimen 3: 2RHZ/4RH2: A partly unsupervised
and partly supervised regimen consisting of
Rifampicin 450mg, Isoniazid 300mg and
Pyrazinamide 1.5g daily for 2 months, the drugs
collected twice-a-month for self-administration,
followed by Rifampicin 600 mg and Isoniazid
600 mg twice-weekly for the next 4 months, the
drugs administered twice-a-week in the clinic under
supervision, because patients tend to become
irregular in the later months.
In addition, where facilities were available,
Streptomycin 0.75g i.m. could be given in the first
2 months in all the 3 regimens**
Treatment policies
The 18 districts were divided into 3 groups of
6 each and allotted to one of the 3 policies described
below:-
Policy A: Patients were to be treated with regimen
1 requiring twice-weekly attendance throughout.
However, if the patient was not able to attend so
often, regimen 2 was offered.
Policy B: Patients were to be treated with regimen
2 only.
Policy C: Patients were to be treated with regimen
3, but as in policy A, regimen 2 could be offered to
patients who were unable to attend the clinic twice
a week.
Management of Patients
Patients startedon short course chemotherapy
had to attend the treatment centre according to the
* Defined as patients with complaints of cough for 2 weeks or more, chest pain and/or fever for 1 month or more, or haemoptysis
at any time.
** In practice, Streptomycin was given only to less than 1% of the patients.
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regimen prescribed. For patients who did not attend
on the due date for drug administration/collection,
defaulter action such as a letter, home visit or a
message was to be taken on the next day. For
patients who did not turn up within 7 days of the fist
action, a second retrieval action (letter/home visit),
was to be taken. Those who defaulted continuously
for a period of one month were considered as
“Lost” to SCC (patients who re-attended after after
one month were managed on individual basis.)
One sputum smear examination for AFB was
to be carried out at 3 months and another at the end
of chemotherapy (6/8m). If the sputum examined at
the end of treatment was found positive, a second
specimen was to be examined. If this smear was also
positive, treatment was to be continued with
Thioacetazone 150 mg and Isoniazid 300 mg daily
up to 9 months (i.e., for an additional 1 or 3 months)
and another sputum examination was undertaken
then. If that was also positive, the patient was to be
referred to the District Tuberculosis Officer (DTO)
for further management.
If a patient developed symptoms and/or signs
of jaundice, Rifampicin and Pyrazinamide were to
be terminatedand Isoniazid withheld, and the patient
put on standard chemotherapy consisting of EH/TH
or SHtw after jaundice had subsided. For mild
arthralgia, analgesics were to be prescribed; if it was
incapacitating or pain persisted despite analgesics,
Pyrazinamide was to be withheld and re-introduced
when the pain subsided. If arthralgia recurred, the
patient was to be referred to the DTO for further
management. Gastro-intestinal upsets and other
minor reactions were to  be  managed
symptomatically.
Conduct of the Project and Role of Tuberculosis
Research Centre (TRC)
The TRC was given the responsibility of
inplementation and monitoring of SCC in the 18
districts under the existing DTPs by the Government
of India. Protocols and detailed work instructions
were prepared by TRC and circulated to the Officers-
in-charge of tuberculosis at the state level and the
DTOs. The work instructions and guidelines were
distributed to all the Peripheral Health Institutions
(PHIs) of these districts through their respective
DTOs. The DTOs and their teams were made
responsible for the implementation and conduct of
the project. Rifampicin and Pyrazinamide were
supplied by the Government of India (courtesy
Swedish International Development Agency),
according to the requirements, indicated twice a
year by the DTOs. Certain modifications in the
format of the monthly returns routinely submitted to
the National Tuberculosis Institute (NTI), Bangalore,
such as, number of PHIs implemented with SCC,
dividing section on treatment into 3 parts to get
information on sputum positive cases started on
SCC or standard regimen and sputumnegative cases
started on standard treatment, putting an additional
column to get information about the reasons for not
starting eligible patients on SCC, etc. were made in
consultation with the NTI, Bangalore. An additional
statistician was posted to these 18 districts to monitor
the programme, collect the required information
and co-ordinate with the TRC.
The monthly and quarterly reports on
tuberculosis and annual cohort reports were sent to
the TRC by the DTOs. When reports were not
received on time, reminders were sent to the
concerned DTOs.
A team consisting of a medical officer,
bacteriologist, statistician andmedical social worker
from TRC visited the District Tuberculosis Centres
(DTCs) and PHIs and held discussions to identify
problems, if any, and suggest remedial measures.
The microscopy facilities were also inspected and
corrective measures such as minor repairs of the
microscopes were undertaken. A sample of positive
and negative sputum slides was read by the TRC
staff. Training programmes were conducted at the
district level for medical and paramedical workers
to get more personnel at the PHI level trained in the
various aspects of the programme. Workshops were
conducted at least once a year, initially at the TRC
and later at a central location combining 3 or 4
districts for in-service training (courtesy, ICMR/
WHO) of medical and paramedical workers involved
in the programme.
Periodically, the DTOs and the state officers
in-charge were briefed by the TRC about the
performance of their districts and attempts were
made to sort out any problems which had been
identified. Thus, the role of the TRC, Madras was
mainly in an advisory capacity to the programme
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officers in addition to providing in-service training
and monitoring.
FINDINGS
Documentation
The observations reported here are based on
the information obtained from the monthly and
quarterly returns on tuberculosis and the annual
cohort reports from the various districts. These
returns were received from all the districts every
month, 57-77% received within one month and rest
after reminders.
Implementation of SCC
Beginning in March 1983, with a district in
Tamil Nadu, SCC was gradually introduced, and by
March 1985 all the 18 districts had been covered.
Efforts were made to make SCC available in all the
PHIs in each of the 18 districts as quickly as
possible.
By 1985, the implementation of SCC in PHIs
was 75% or more in 8 of the 18 districts and less than
50% in 7 districts (Table 1). By 1989, 14 districts
had implemented SCC in 75% or more of the PHIs,
including 9 with 100% and none had less than 50%
implementation. By 1991, 15 districts had
implemented SCC in 75% or more of the PHIs,
including 10 districts with 100% and 3 districts
with 90-99% implementation of the PHIs. In the
remaining 3 districts, SCC was implemented in
73%, 50% and 55% of the PHIs. A visit was
undertaken by TRC team to 2 districts where the
implementation was low. It was observed that the
major reasons for non-implementation were long
Table 1. SCC implementation in PHIs
SCC imple No. of districts with SCC implemented according to year
-mented
PHIS (%) 1985 1986 1987 1988 1989 1990 1991
100 6 5 4 5 9 9 10
90-99 1 1 2 2 2 2 3
75-89 1 1 0 1 3 4 2
50-74 3 3 6 8 4 3 3
<50 7 8 6 2 0 0 0
Note: The number of PHIs increased year to year in some districts, which could have resulted in a reduction in the
percentage implemented
Table 2. Case finding activity and PHI contribution per district per year
DTC sputa PHI sputa PHI contribution
Year
1985
1986
1987
1988
1989
1990
1991
Examined Positive Examined Positive Examined Positive Examined Positive Examined Positive
No. No. No. No. c / a + c  d / b + d
(a) (b) (%)+ (%)+ (c) (d) (%)+ (%)+ (%) (%)
4629 531 100 100 10644 511 100 100 70 49
4426 561 96 106 12015 618 113 121 73 52
4777 543 103 102 12267 567 115 111 72 51
4967 561 107 106 12191 515 115 101 71 48
4345 542 94 102 11940 650 112 127 73 55
4027 530 87 100 12518 729 118 143 76 58
4062 554 88 104 12297 812 116 159 75 59
+ based on 1985 figure
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distance and inaccessible PHIs. The overall
implementation with SCC was 66% of the DTP-
implemented PHIs in 1985 and 93% by 1991. And,
as a proportion of the total PHIs, the implementation
in respect of SCC was 54% in 1985 and 87% in 1991.
Case-finding activity
The case-finding activity in the districts was
assessed by the total number of sputa examined and
the sputum positive cases detected per year.
Excluding 2 districts from where adequate
information was not received for the initial 2-years
period, theaverage sputum examination was 4629
per DTC in 1985 (Table 2). Considering 1985 as the
baseline, there was no definite trend over the years
as far as the DTCs were concerned (4629 in 1985
and 4062 in 1991). However, at the PHIs, the
average sputum examination registered an increase
from 10644 in 1985 to 12297 in 1991. Even though
there was no increase in the sputum examinations at
the DTC, the sputum positives detected remained
fairly constant, the range being 530 to 561. The
average number of sputum positive cases detected
per year at the PHIs registered an increase from 511
in 1985 to 812 in 1991. The overall contribution of
the PHIs towards sputum examinations was 70 and
75% of the total examinations and 49 and 59% with
regards to sputum positive cases detected,
respectively. Combining the DTCs and the PHIs,
the increase in sputum examinations was 7% and in
sputum positives detected 31%, between 1985 and
1991.
The total population of the 18 districts was
39.8 million, as per 1981 census. Considering the
population aged 5 years or more to be around 85%,
and the prevalence of sputum positive cases to be
about 4 per 1000, and that about 50% of these cases
attend a health centre and 80% of these cases can be
detected by microscopy, the expected diagnosis of
sputum positive cases was 54,128 per year, while
the actual number diagnosed was 21,948 per year -
an efficiency of 41%. However, there was a wide
variation in case finding efficiency between the
districts (range: 15% to 94%).
Condition of microscopes
Using aquestionnaire, it was reported from 10
of the 18 districts that 250 microscopes were
defective. A TRC team detected 151 defective
microscopes and undertook necessary repairs.
A total of 1010 sputum smear slides were
collected during the supervisory visits to the districts
and read at TRC later. It was found that there was
95% agreement between the readings, there being
4.5% under reading and 0.5% over reading of the
smears in the districts.
Prescribed SCC
During the 7-year period, a total of 164,695
sputum positive cases were diagnosed in the 18
districts and 1,37,099 (83%) were eligible to be
treated with SCC (Table 3). However, only 84,704
(62%) of the patients were started on SCC (66% in
policy A, 52% in policy B and 67% in policy C
districts). Of these, 75% of patients in policy A and
65% of patients in policy C districts were treated
with regimen 2 (Annexure). Among the 6 policy A
districts, excluding one district where only regimen
1 was implemented, 16% were treated with regimen
1. However, there was a wide variation between
districts (1-50%).
Table 3. Policy-wise distribution of smear positive
patients, eligible for SCC and started on SCC
Smear Eligible Put on
Policy positives for SCC SCC
No. No. % of No. % of
(a) (b) (a) (b)
A 68185 58152 85 38252 66
B 52446 42270 81 21815 52
C 44064 36677 8 3  2 4 6 3 7  6 7
Total 164695 137099 83 84704 62
Reasons for not starting SCC
The reason(s) for not starting SCC was/were
available for 43% of 52395 patients (Table 4) and
have been classified as reasons attributable to
patients (58%), organisational/administrative (35%)
causes and other reasons (7%). Of the reasons
attributable to patients, 23% were living too far
away, 15% were likely to migrate from the
given address and 10% were too old or sick. Of
the organisational/administrative reasons,
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non-availability of SCC drugs and non-
implementation of SCC in the PHIs accounted for
13% and 11%, respectively.
Table 4. Reason(s) given for not starting SCC
Patients
No. %
(a) Eligible but not put on SCC 52395
(b) Reason available for}
not being put on SCC} 22734 43(% of a)
A. Attributable to patients 13167 58*
Living too far away 5 2 0 6  2 3
Likely to migrate 3486 15
Too old or sick 2237 10
Initial defaulter 451 2
Travel too expensive, non-}
availability of transport,}
loss of wages etc.} 1787 8
B. Organisational/ 7 9 3 9  3 5
Administrative Causes
SCC drugs not available 2551 13
SCC not implemented 2551 11
Clinic hours not convenient 422 2
Patients admitted in hospital 261 1
Miscellanceous 1836 8
C. Others 1628 7
*. This percentage and all subsequent ones are based on
(b).
Cohort analysis for treatment completion
Analyses of treatment completion were done
based on the treatment cards returned to the DTCs.
Of the 74,930 patients started on SCC in 17 districts,
excluding 1 district where only limited information
on a few patients was available, 64,729 patients
(86%) were included in the cohort analysis. The
proportion of patients included was 90% or more in
13 districts.
Treatment completion
In policy A districts, 52% of the 24,945
patients included in the cohort analysis had received
80% or more of their chemotherapy; the
corresponding figures were 55% of 18,450 in Policy
B districts and 55% of 21334 in Policy C districts,
the overall treatment completion being 54%. Detailed
analyses showed that the treatment completion was
50% to 54% in policy A, 49% to 64% in policy B and
46% to 62% in policy C districts. In the 1990-91
cohort, the treatment completion was 50%, 64% and
62% for the 3 policies respectively (data not
tabulated).
Since a proportion of patients in Policy A and
C districts were treated with regimen 2, an analysis
was undertaken to find out the treatment
completion according to the regimen (Table 5). The
proportion of patients receiving 80% or more of
chemotherapy was 49% of 12929 patients (range
46-71%) treated with regimen 1 which was a fully
supervised regimen, 54% of 44383 patients treated
with regimen 2, a self-administered regimen (range
28-86%), and 61% of 7417 patients treated with
regimen 3, a partially supervised. regimen (range
39-79%). Considering the 20,346 patients who were
started on regimens 1 and 3, the proportion of
patients completing 80% or more of chemotherapy
was 54%, similar to the 54% of 44383 patients
started on regimen 2.
In regimen 1, 39% of patients had received
50% or less of chemotherapy, including 22%
receiving 25% or less. The corresponding figures
were 38% and 27% for regimen2, and 33% and 17%
for regimen 3.
The proportions of patients ‘lost’ from
chemotherapy according to regimen were 45% with
the fully supervised twice weekly regimen, 40%
with the unsupervised regimen and 33% with the
partially supervised regimen (data not tabulated).
Bacteriology at the end of chemotherapy
A sputum specimen was to be examined at the
end of chemotherapy for all patients completing
treatment. However, the coverage for sputum
examination was 64% of patientson regimen 1, 80%
on regimen 2 and 84% on regimen 3. Of those
examined, 95%, 99% and 99% respectively were
negative by smear (Table 5). Sputum smear results
at the end of chemotherapy were available for 4
cohort periods for patients treated with standard
chemotherapy. Of the 8847 patients eligible for
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Table 5. Treatment completion rate and sputum smear status at the end of treatment, according to regimen
Regimen
End of treatment
Total Completed Patients avail- Sputum sputum
patients# >80% Treatment able for sputum examined negative
No. examination
No. % No.
(a) (b) (b/a) (c) (d) (e/d)
1. 2RHZ2/4RH2
No. of
Patients
Range
12929 6349 49 5334 3441 64 3276 95
89 - 63 - 46 - 59 - 5 - 8 - 5 - 93 -
8984 4089 71 3300 1716 100 1590 100
2. 2RHZ/6TH
No. of
Patients
Range
44383 23944 54 22609 18065 8 0  1 7 8 4 2 99
22 - 19 - 28 - 15 - 14 - 30 - 14 - 95 -
6371 4458 86 4232 4065 100 4039 100
3. 2RHZ/4RH2
No. of
Patients
Range
7417 4541 61 4374 3665 84 3643 99
49 - 29 - 39 - 22 - 21 - 75 - 21 - 98 -
2488 1696 79 1636 1425 96 1410 100
# From inception of SCC programme up to June 1991.
sputum examination at the end of chemotherapy,
4002 (45%) had sputum examination done and of
these, 96% were negative by smear (data not
tabulated).
Comparison of treatment completion among 4
cohorts of SCC and standard chemotherapy
Concurrent analyses were done for 4 cohort
periods to compare the treatment completion rates
between SCC and standard regimen. The overall
treatment completion with SCC regimens for the 4
cohort periods ranged from 51% to 55% (Table 6).
Considering the standard chemotherapy cohorts,
the treatment completion rate increased from 29%
in 1986-87 cohort to 41% in 1987-88 cohort, 45% in
1988-89 cohort and 40% in 1989-90 cohort.
Considering the proportions of patients ‘lost’
from treatment in SCC and standard regimen (data
not tabulated), 18% and 20% ofpatients, respectively
were lost afterreceiving the number of doses due for
the first month of treatment, 35% and 34%,
respectively, up to 3 months and 44% in each
regimen up to 5 months.
Adverse reactions
Information on adverse reactions was not
available in the periodic returns from all the districts.
However, one district had reported less than 1%
each ofjaundice, vomiting and gastritis8. In addition,
giddiness (1.6%) and arthralgia (1.7%) was also
reported from the same district. Further, change of
treatment for any reason (including adverse
reactions, non-availability of SCC drugs and inability
to attend frequently, etc.) was reported only in 4%
of cases in regimens 1 and 3 and 2% in regimen 2.
DISCUSSION
The observations reported here cover a period
of 7 years after introducing SCC in 18 districts
spread all over India under the existing programme
conditions. The SCC implementation was
undertaken in a phased manner, and by March 1985,
all the districts had implemented SCC. By 1985, the
coverage for implementation was 66% of the PHIs
which increased to 93% by 19919.
Considering the case-finding activity, the
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overall efficiency was of the order of 41% . This rate
is similar to the national average of about 30-
36%10,11 but substantially less than the expected
potential of about 60-65%11,12, which is very near the
WHO target of 70%13.
Combining DTCs and PHIs, the total number
of sputum examinations had registered an increase
of 7% and in sputum positives of 31% between 1985
and 1991. There was an increase in the number of
sputum examinations by 16% at the PHIs and a
decrease by 12% at the DTCs, a trend in the expected
direction. The contribution of the PHIs during the 7-
year period was in the range of 70-76% in respect of
sputum examination and 4859% with respect to
detection of smear positive cases. The national figures
during the same period were similar, being 70-72%
and 49-53% respectively2,14-16. Further, improvement
is required in supplies given for sputum microscopy.
The fact that a large number of the microscopes in
the 18 districts needed repairs suggests the need for
frequent supervision and service facilities. A check
on the quality of sputum microscopy through random
samples had shown 95% agreement between the
readings at the district level and at TRC. Thus, the
quality of the reading of sputum smears was found
to be satisfactory. In addition, utilisation of volunteer
workers like National Service Scheme (NSS)
students, traditional birth attendants (Dais) and
literate youth, in difficult terrains to improve
detection of symptomatics is being evaluated at our
Centre.
The proportion of eligible patients started on
SCC was 62% in the present study. In a recent report
from the NTI, Bangalore, it was observed that
49.4% of the smear positive cases diagnosed in 248
districtshad been started on SCC regimens: of these,
only 2.8% were treated with a supervised twice
weekly regimen of 6-month duration9. In the present
report, of the 6 districts with policy A, one district
only had the fully supervised regimen implemented.
In the remaining 5 districts, 16% were started on a
fully supervised twice-weekly regimen. However,
there was a wide variation (1%-50%) between the 5
districts.
It was also observed that 38% of eligible
patients were not started on SCC, even though they
could be prescribed a regimen requiring only twice-
a-month attendance for 8 months. The reasons for
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not starting SCC were available only in 43% of the
patients. Of these, 58% were attributable to the
patients like living too far away, likely to migrate
and too old or sick. It is possible to solve some of
these problems by decentralising the treatment,
utilising the sub-centres which cater to a relatively
small population of 5000 whereas the PHCs cater to
a population of 30,000. The patients likely to
migrate also could be given SCC with improvement
in the implementation of SCC. Considering the
administrative/organisational reasons, non-
implementation of SCC and non-availability of
drugs (either due to inadequate supply or failure to
indent for the drugs on time) were the main problems
faced. The monthly meetings of the DTO with the
PHI staff could be utilised to introduce the SCC
regimens and motivate the staff to implement SCC
at the respective PHIs. It is also possible to take
stock of the drug position at the PHIs during these
meetings and, if necessary, redistribute the excess
stock in some PHIs to tide over the drug shortage
elsewhere. Timely indenting and streamlining of
drug supply are also essential.
With respect to case-holding, during the 7-
year period, approximately 54% completed 80% or
more of treatment, figures similar to the 53%
completing 75% or more of treatment reported by
NTI9. Detailed analyses have shown that there was
no difference in treatment completion rates between
the different cohort periods. These completion rates
are better than the 27-34% reported in the NTP with
12-month regimens1,2. The completion rate with 12
month regimens for concurrent cohorts in these 18
districts was 29% in the 1986-87 cohort which
increased to 40-45% in subsequent cohorts. It was
found that the treatment completion was 54% in
regimen 2 where patients had to attend twice a
month, and 49% and 61% in regimens 1 and 3,
respectively, where patients had to attend twice a
week either throughout the 6-month period or for a
4-month period, respectively. The completion rates
for the patients treated with the supervised regimen
involving twice-weekly attendance either throughout
or partially and for the unsupervised regimen in 12
districts, were similar. Thus, the frequency of
clinic attendance does not appear to have had any
influence on the treatment completion rates.
Considering the proportion of patients ‘lost’
fromtreatment, 18% in SCC and 20% in standard
chemotherapy were lost after receiving the doses
due for the 1st month, 35 % and 34%, respectively,
for up to 3 months and 44% in each for up to 5
months. Thus, it appears that the duration for
which treatment is given exerts more influence
on patient compliance than the drugs given.
In an attempt to find out the reasons for
patients discontinuing treatment, visits were made
in 2 districts to the homes of patients who had been
‘lost’ to treatment17. It was found that in an
appreciable proportion ofpatients, thereasons, such
as adverse reactions, inaccurate or inadequate address
and abatement of symptoms are correctable. This
Centre had evolved an inexpensive and efficient
system of obtaining accurate addresses of patients
by utilising an “address card system”18. This system
was employed under programme conditions in one
district and it was found that the system was
acceptable and could improve the accuracy of
addresses19. This is essential because the defaulter
retrieval procedure in the programme depends
largely on letter posting.
In earlier studies, one-time motivation at the
start of treatment was found to be inadequate20 but
motivation of the patients together with their family
members every month during the initial three months
of treatment resulted in better drug collection2l. A
study at this Centre22 had also shown that there was
a 10% increase in the compliance rate among
patients motivated initially only and by 20% among
those motivated at 0, 1, 2 and 5 months, compared to
patients who were not subjected to motivation.
Treatment completion of 80% or more with
SCC has been reported from other countries,
adopting special measures to improve treatment
adherence. Some of the measures used were home
visit by a health worker in Botswana23, a parish
priest in the Philippines24 and a nursing officer in
Beijing25, whereas in Tanzania26, patients were
hospitalised during the initial period of treatment.
Application of any of these measures on a nation-
wide basis in India would require much more
resources than are currently available. However,
alternative approaches such as utilisation of the
available community workers forretrieving patients
is likely to improve case-holding without additional
expenditure. This Centre is currently investigating
different strategies, such as utilisation of
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multipurpose workers (MPW), student volunteers
of National Service Scheme (NSS), traditional birth
attendants (Dais) at village level, drug supply through
subcentres and patient-to-patient motivation in
promoting patient compliance. The results of such
studies will be useful in strategic planning of health
care delivery.
A high proportion of patients for whom sputum
examination was done at the end of treatment,
namely 95-99% were smearnegative. When a sample
of sputum specimens from 2 districts was examined
by culture at this Centre, 80% of 408 were negative
in a district where the fully supervised regimen was
prescribed and 92% of 876 in a district where the
partially supervised regimen was prescribed27.
Studies are underway to estimate the relapse rates
among patients put on SCC under DTP.
It was reported from this Centre that among a
group of 2306 patients treated with SCC in the above
districts with the fully supervised regimen, 42% had
completed 80% or more of treatment28. A one-time
sputum specimen was collected (corresponding to
6-36 months after the start of treatment) and 79% of
the patients who had received 80% or more of
chemotherapy were negative by culture. It was also
observed that even among patients who had received
less than 50% of the drugs, 52% were culture
negative. However, this Centre is undertaking another
study to corroborate this finding by collecting
periodic sputum specimens from the same district.
The following key issues are vital for the
success of the programme: proper documentation
and timely reporting2, motivated and trained
personnel at the periphery leve110,29, uninterrupted
drug supply, good maintenance of microscopes and
regular check of sputum microscopy, periodic
evaluation and surveillance at all levels, in-service
training for both technical andmanagerial personnel,
and availability of functioning transport with
adequate fuel supply to facilitate mobility of
supervisory staff.
A study of the relative importance of the 3
components of the programme, namely, case-
finding, case-holding and chemotherapy has been
reported30. In these 18 districts, the case-finding
has been 41 %, thecase-holding to be 54% and the
regimen used in the present project are of near
100 % efficacy (in clinical trials). In this situation,
the overall impact of the programme could only
be around 22 %. There is, thus, a need to evolve
strategies to improve case-finding and case-
holding, the two deficient components of the
programme.
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Annexure: Demographic data, case finding activity and application of SCC in 18 districts
District State
Popula- No. of PHIs New Posi t ive Eligi- Put on SCC 1st
tion under DTP smears ble for Reg*
(000000) 1985 1991 examined SCC %
No. No. No. No.
Policy A
N. Arcot Tamil Nadu 4.50
Puri Orissa 2.92
Baroda Gujarat 2.56
Thane Maharashtra 3.35
Ujjain Madhya Pradesh 1.12
Dehra Dun Uttar Pradesh 0.76
Policy B
Karnal Haryana 1.32
Kanpur Uttar Pradesh   3.74
Nagpur Maharashtra 2.59
Rajkot Gujarat 2.09
Raichur Karnataka 1.78
Sagar Madhya Pradesh   1.32
Policy C
Pondicherry Union Territory   0.44
Vidisha Madhya Pradesh   0.78
Aurangabad Maharashtra 2.43
Varanasi Uttar Pradesh 3.70
Sabarkantha Gujarat 1.50
W. Godavari  Andhra Pradesh    2.87
87 94 42863 2034 5 1990 1142 57 91**
74 82 14390 594 4 511 377 74 50
70 85 18657 2557 14  1866 1119 60 20
84 94 31460 1780 6 1746 1380 79 1
30 54 9150 867 9 551 373 68 50
23 27 10359 975 9 810 570 70 2
20 29 10130 751 7 636 326 51
26 33 20282 1466 7 1032 353 34
85 53@ 27346 2184 8 2035 988 49
29 75 10914 921 8 682 462 68
26 73 13127 930 7 767 459 60
38 48 7743 716 9 446 330 74
52 58 19345 865 4 455 349 77 99
26 45 7009 561 8 469 379 81 23
40 50 13947 1276 9 1189 791 67 3
22 33 17174 914 5 697 464 67 69
41 69 19521 1392 7 1274 946 74 1
37 61 16793 1165 7 1060 534 50 78
# Figures given under these columns are mean values per year.
* Proportion prescribed the main regimen (in Policies A & C districts),
** 2nd regimen implemented in 1990
@ Due to administrative reasons, some PHIs were amalgamated.
